Status:
COMPLETED
Outcome of TAMIS Mucosal Resection in Patients With ODS
Lead Sponsor:
Medical University of Vienna
Conditions:
Constipation, Impaction, and Bowel Obstruction
TAMIS Mucosectomy
Eligibility:
All Genders
18-90 years
Brief Summary
Patients, aged 18 - 90 years, undergoing TAMIS mucosectomy at the Department of General Surgery at the Medical University of Vienna are enrolled into our study. Primary endpoint is the outcome (impro...
Detailed Description
Various surgical approaches for the treatment of obstructed defecation syndrome (ODS) commonly associated with rectocele and rectal intussusception have been investigated in the literature. Methods su...
Eligibility Criteria
Inclusion
- Need of minimal invasive mucosal resection due to obstructed defecation syndrome after several unsuccessful conservative treatments over a period of more than 6 months with presence of an organic cause (Symptomatic intussusception with or without rectocele) in medical examinations (defecography, endoluminal ultrasound, endoanal manometry)
- Age: 18-90 years
- Ability and willingness to understand and comply with planned interventions during the study.
- Voluntarily signed informed consent after a full explanation of the study to the participant.
Exclusion
- Any physical or mental disorder could interfere with the participant's safety during the clinical trial or with the study objectives.
- Inability to communicate well with the investigator due to language problems or reduced mental development.
- Inability or unwillingness to give written informed consent.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06522399
Start Date
August 1 2021
End Date
October 1 2023
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090